Genelux Corporation (GNLX)
Total Valuation
Genelux has a market cap or net worth of $160.31 million. The enterprise value is $131.77 million.
Market Cap | 160.31M |
Enterprise Value | 131.77M |
Important Dates
The next estimated earnings date is Thursday, May 2, 2024, after market close.
Earnings Date | May 2, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Genelux has 26.66 million shares outstanding. The number of shares has increased by 160.18% in one year.
Shares Outstanding | 26.66M |
Shares Change (YoY) | +160.18% |
Shares Change (QoQ) | +4.55% |
Owned by Insiders (%) | 22.49% |
Owned by Institutions (%) | 21.84% |
Float | 20.18M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 673.56 |
Forward PS | n/a |
PB Ratio | 6.67 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 553.64 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.56, with a Debt / Equity ratio of 0.06.
Current Ratio | 3.56 |
Quick Ratio | n/a |
Debt / Equity | 0.06 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -53.64 |
Financial Efficiency
Return on equity (ROE) is -758.80% and return on invested capital (ROIC) is -79.89%.
Return on Equity (ROE) | -758.80% |
Return on Assets (ROA) | -117.00% |
Return on Capital (ROIC) | -79.89% |
Revenue Per Employee | $10,818 |
Profits Per Employee | -$1.14M |
Employee Count | 22 |
Asset Turnover | 0.01 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -80.16% in the last 52 weeks.
Beta (1Y) | n/a |
52-Week Price Change | -80.16% |
50-Day Moving Average | 8.22 |
200-Day Moving Average | 18.03 |
Relative Strength Index (RSI) | 35.66 |
Average Volume (30 Days) | 119,542 |
Short Selling Information
The latest short interest is 1.85 million, so 6.92% of the outstanding shares have been sold short.
Short Interest | 1.85M |
Short Previous Month | 1.59M |
Short % of Shares Out | 6.92% |
Short % of Float | 9.14% |
Short Ratio (days to cover) | 9.20 |
Income Statement
In the last 12 months, Genelux had revenue of $238,000 and -$25.03 million in losses. Loss per share was -$1.34.
Revenue | 238,000 |
Gross Profit | 238,000 |
Operating Income | -20.26M |
Pretax Income | -25.03M |
Net Income | -25.03M |
EBITDA | -23.92M |
EBIT | -24.57M |
Loss Per Share | -$1.34 |
Balance Sheet
The company has $29.87 million in cash and $1.33 million in debt, giving a net cash position of $28.54 million or $1.07 per share.
Cash & Cash Equivalents | 29.87M |
Total Debt | 1.33M |
Net Cash | 28.54M |
Net Cash Per Share | $1.07 |
Equity / Book Value | 24.03M |
Book Value Per Share | 0.90 |
Working Capital | 22.42M |
Cash Flow
In the last 12 months, operating cash flow was -$14.88 million and capital expenditures -$782,000, giving a free cash flow of -$15.67 million.
Operating Cash Flow | -14.88M |
Capital Expenditures | -782,000 |
Free Cash Flow | -15.67M |
FCF Per Share | -$0.60 |
Margins
Gross margin is 100.00%, with operating and profit margins of -8,511.76% and -10,514.71%.
Gross Margin | 100.00% |
Operating Margin | -8,511.76% |
Pretax Margin | -10,514.71% |
Profit Margin | -10,514.71% |
EBITDA Margin | -10,050.00% |
EBIT Margin | -10,322.27% |
FCF Margin | -6,581.93% |
Dividends & Yields
Genelux does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -160.18% |
Shareholder Yield | -160.18% |
Earnings Yield | -15.61% |
FCF Yield | -9.77% |
Analyst Forecast
The average price target for Genelux is $32.50, which is 422.42% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $32.50 |
Price Target Difference | 422.42% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | 64.13% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Genelux has an Altman Z-Score of -0.83 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.83 |
Piotroski F-Score | 3 |